Research Frontiers (REFR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 72 | 359 | 130 | 560 | 178 |
| Cost of Goods | 711 | 522 | 776 | 637 | 642 |
| Gross Profit | -639 | -162 | -646 | -77 | -464 |
| Operating Expenses | 846 | 663 | 945 | 799 | 802 |
| Operating Income | -774 | -304 | -815 | -240 | -624 |
| Other Income | 8 | 5 | 11 | 62 | 16 |
| Pre-tax Income | -766 | -299 | -804 | -178 | -608 |
| Net Income Continuous | -766 | -299 | -804 | -178 | -608 |
| Net Income | $-766 | $-299 | $-804 | $-178 | $-608 |
| EPS Basic Total Ops | -0.02 | -0.01 | -0.02 | -0.01 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.01 | -0.02 | -0.01 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.01 | -0.02 | -0.01 | -0.02 |
| EBITDA(a) | $-727 | $-257 | $-768 | $-193 | $-488 |